In today’s trade, shares of Angel One, Tata Steel, Shriram Finance, IndiGo, Eternal among others will be in focus due to various news developments.
Angel One
Angel One’s board of directors will meet on January 15 to consider a stock split and declare its first interim dividend for the financial year 2025-26 along with the announcement of its December quarter earnings. While the interim dividend will be paid only if approved by the board, the brokerage firm announced January 21, 2026 as the record date for determining eligible shareholders.Tata Steel
Steel major Tata Steel achieved its best-ever quarterly crude steel production of 6.34 million tons in Q3, recording a 12% year-on-year and sequential production growth primarily led by higher output at Jamshedpur and Kalinganagar facilities. The improvement in production also led to the company’s best-ever quarterly deliveries as Tata Steel India crossed the 6 million-ton-mark for the first time.
IndiGo
Competition Commission has sought information from IndiGo as well as aviation regulator DGCA in order to assess whether the country’s largest airline indulged in unfair business practices against the backdrop of massive flight cancellations last month, PTI reported.
Eternal
Eternal, the parent entity of Zomato and Blinkit, has received a goods and services tax (GST) demand order, along with interest and penalty, amounting to Rs 3.69 crore for the period April 2019 to March 2020. The order was passed by the Additional Commissioner of State Tax (Appeals), West Bengal.
Shriram Finance
Three Proxy advisory firms have supported all three proposals, including stake dilution in favour of Japan-based MUFG Bank, for the Shriram Finance EGM to be held next week. The extraordinary general meeting has been called on January 14 to secure a nod for fund infusion of Rs 39,618 crore or $4.4 billion from MUFG Bank by diluting 20% stake through preferential issue shares.
United Breweries
United Breweries Limited, part of alcobev maker Heineken, launched Kingfisher Smooth, a strong beer aiming to cater to next-generation consumers. This launch expands the Kingfisher portfolio within India’s mainstream strong beer segment.
Gland Pharma
Gland Pharma, a generic injectable and ophthalmic focused pharmaceutical company, has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application filed for Olopatadine Hydrochloride The Product is therapeutically equivalent to the reference listed drug (RLD), Pataday Once Daily Relief, 0.7%, of Alcon Laboratories Inc (Alcon).
